gray market retatrutide price Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide Commercial Availability Timeline: Key
Description
The Triple Therapy program is intended for patients who do not meet the BMI requirements to start a GLP-1 program but still seek help managing their weight
Retatrutide: The Triple GLP-1 / GIP / Glucagon Agonist If tirzepatide is a dual agonist, retatrutide is the answer to the obvious next question: what happens if you add a third receptor
Diabetologia 66:965985
Side effects include dizziness, vomiting, and diarrhea
